The McGill University Health Centre is one of two major healthcare networks in the city of Montreal, Quebec. It is affiliated with McGill University and is one of the largest medical institutions in Canada. It is the largest hospital system in Canada by bed capacity.

There are 1,379 beds in McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre.

During the past decade, McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Laval University" with 1 trials as a collaborator, "Mount Sinai Hospital, Montreal" with 1 trials as a collaborator and "Université de Montréal" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre" are "Breathlessness" (2 trials), "Heart Failure" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Chronic Obstructive Pulmonary Disease (COPD)" (1 trials) and "Exercise Intolerance" (1 trials). Many other conditions were trialed in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre" in a lesser frequency.

Most popular intervention types in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre" are "Drug" (3 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Administration of FluMist (Live Attenuated Influenza Vaccine)" (1 trials), "CWS" (1 trials), "Cannabis" (1 trials) and "Cardiopulmonary Exercise Testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".